Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse
- PMID: 16059637
- DOI: 10.1359/JBMR.050503
Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse
Abstract
Stromal/osteoblastic cell expression of RANKL and M-CSF regulates osteoclastogenesis. We show that aging is accompanied by increased RANKL and M-CSF expression, increased stromal/osteoblastic cell-induced osteoclastogenesis, and expansion of the osteoclast precursor pool. These changes correlate with age-related alterations in the relationship between osteoblasts and osteoclasts in cancellous bone.
Introduction: Bone mass is maintained through a balance between osteoblast and osteoclast activity. Osteoblasts regulate the number and activity of osteoclasts through expression of RANKL, osteoprotegerin (OPG), and macrophage-colony stimulation factor (M-CSF). To determine whether age-related changes in stromal/osteoblastic cell expression of RANKL, OPG, and M-CSF are associated with stimulation of osteoclastogenesis and whether the osteoclast precursor pool changes with age, we studied cultures of stromal/osteoblastic cells and osteoclast precursor cells from animals of different ages and examined how aging influences bone cell populations in vivo.
Materials and methods: Osteoclast precursors from male C57BL/6 mice of 6 weeks (young), 6 months (adult), and 24 months (old) of age were either co-cultured with stromal/osteoblastic cells from young, adult, or old mice or treated with M-CSF, RANKL, and/or OPG. Osteoclast precursor pool size was determined by fluorescence-activated cell sorting (FACS), and osteoclast formation was assessed by measuring the number of multinucleated TRACP(+) cells and pit formation. The levels of mRNA for RANKL, M-CSF, and OPG were determined by quantitative RT-PCR, and transcription was measured by PCR-based run-on assays. Osteoblast and osteoclast numbers in bone were measured by histomorphometry.
Results: Osteoclast formation increased dramatically when stromal/osteoblastic cells from old compared with young donors were used to induce osteoclastogenesis. Regardless of the origin of the stromal/osteoblastic cells, the number of osteoclasts formed from the nonadherent population of cells increased with increasing age. Stromal/osteoblastic cell expression of RANKL and M-CSF increased, whereas OPG decreased with aging. Exogenously administered RANKL and M-CSF increased, dose-dependently, osteoclast formation from all donors, but the response was greater in cells from old donors. Osteoclast formation in vitro positively, and the ratio of osteoblasts to osteoclasts in vivo negatively, correlated with the ratio of RANKL to OPG expression in stromal/osteoblastic cells for all ages. The effects of RANKL-induced osteoclastogenesis in vitro were blocked by OPG, suggesting a causal relationship between RANKL expression and osteoclast-inducing potential. The osteoclast precursor pool and expression of RANK and c-fms increased with age.
Conclusions: Our results show that aging significantly increases stromal/osteoblastic cell-induced osteoclastogenesis, promotes expansion of the osteoclast precursor pool and alters the relationship between osteoblasts and osteoclasts in cancellous bone.
Similar articles
-
Estrogen and testosterone use different cellular pathways to inhibit osteoclastogenesis and bone resorption.J Bone Miner Res. 2005 Dec;20(12):2224-32. doi: 10.1359/JBMR.050803. Epub 2005 Aug 1. J Bone Miner Res. 2005. PMID: 16294275
-
Role of IGF-I signaling in regulating osteoclastogenesis.J Bone Miner Res. 2006 Sep;21(9):1350-8. doi: 10.1359/jbmr.060610. J Bone Miner Res. 2006. PMID: 16939393 Free PMC article.
-
Age of donor alters the effect of cyclic hydrostatic pressure on production by human macrophages and osteoblasts of sRANKL, OPG and RANK.BMC Musculoskelet Disord. 2006 Mar 6;7:21. doi: 10.1186/1471-2474-7-21. BMC Musculoskelet Disord. 2006. PMID: 16519799 Free PMC article.
-
Osteoprotegerin and its ligand: a new paradigm for regulation of osteoclastogenesis and bone resorption.Osteoporos Int. 2000;11(11):905-13. doi: 10.1007/s001980070028. Osteoporos Int. 2000. PMID: 11193242 Review.
-
Osteoclast differentiation by RANKL and OPG signaling pathways.J Bone Miner Metab. 2021 Jan;39(1):19-26. doi: 10.1007/s00774-020-01162-6. Epub 2020 Oct 20. J Bone Miner Metab. 2021. PMID: 33079279 Review.
Cited by
-
Single-cell multi-omics identify novel regulators required for osteoclastogenesis during aging.iScience. 2024 Aug 18;27(9):110734. doi: 10.1016/j.isci.2024.110734. eCollection 2024 Sep 20. iScience. 2024. PMID: 39280596 Free PMC article.
-
Mesenchymal Stem Cell Transplantation for the Treatment of Age-Related Musculoskeletal Frailty.Int J Mol Sci. 2021 Sep 29;22(19):10542. doi: 10.3390/ijms221910542. Int J Mol Sci. 2021. PMID: 34638883 Free PMC article. Review.
-
Passage-affected competitive regulation of osteoprotegerin synthesis and the receptor activator of nuclear factor-kappaB ligand mRNA expression in normal human osteoblasts stimulated by the application of cyclic tensile strain.J Bone Miner Metab. 2009;27(6):653-62. doi: 10.1007/s00774-009-0085-3. Epub 2009 May 19. J Bone Miner Metab. 2009. PMID: 19449178
-
NF-κB RelB negatively regulates osteoblast differentiation and bone formation.J Bone Miner Res. 2014 Apr;29(4):866-77. doi: 10.1002/jbmr.2108. J Bone Miner Res. 2014. PMID: 24115294 Free PMC article.
-
DNA damage and senescence in osteoprogenitors expressing Osx1 may cause their decrease with age.Aging Cell. 2017 Aug;16(4):693-703. doi: 10.1111/acel.12597. Epub 2017 Apr 12. Aging Cell. 2017. PMID: 28401730 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous